19.10.2005 – 20:54

Sartorius AG

euro adhoc: Sartorius AG
Financial Figures/Balance Sheet
Ad hoc Announcement According to Section 15 of the German Securities Trading Act (WpHG) Figures for the First Nine Months of 2005 Group sales revenue up 4.7%; currency-adjusted figure up 5.6%

  Disclosure announcement transmitted by euro adhoc.
  The issuer is responsible for the content of this announcement.

19.10.2005

In the first nine months of fiscal 2005, Group sales revenue rose
4.7% (currency adjusted: +5.6%) to EUR353.5 million (previous year:
EUR337.5 mn). Sales revenue for the Biotechnology Division climbed
8.3% (currency-adjusted: +9.2%) to EUR185.0 million (EUR170.8 mn). In
the Mechatronics Division, sales revenue increased 1.1%
(currency-adjusted: +1.8%), attaining EUR168.5 million (EUR166.6 mn).
At EUR365.3 million, order intake at the Group level was up 5.1%
(currency adjusted: +5.8%) from the year-earlier figure (EUR347.6
mn). EBITDA grew 8.2% to EUR39.6 million (EUR36.6 mn); EBIT surged
25.6% to EUR25.5 million (EUR20.3 mn). For the Biotechnology
Division, EBIT jumped significantly from EUR10.2 million to EUR15.2
million, whereas EBIT for the Mechatronics Division at EUR10.3
million was slightly above the previous year’s level (EUR10.1 mn).
The Group EBIT margin improved from 6.0% to 7.2%. Earnings per share
climbed from EUR0.55 to EUR0.79. Nine-month net cash flow attained
EUR13.7 million (EUR21.8 mn). Our gross debt dropped EUR4.4 million
relative to December 31, 2004, and as of September 30, 2005, is at
EUR81.2 million (net debt: EUR73.6 mn). On the basis of the
nine-month figures for 2005, we continue to adhere to our growth and
earnings targets for the current financial year. We expect a further
increase in earnings to an EBIT of over eight percent of consolidated
sales revenue and full-year growth below the rate of the first nine
months.

end of announcement                               euro adhoc 19.10.2005 20:19:08

Further inquiry note:

Andreas Wiederhold
Phone: +49.551.308.1668
andreas.wiederhold@sartorius.com

Branche: Biotechnology
ISIN: DE0007165607
WKN: 716560
Index: Prime Standard, CDAX, Prime All Share, Technologie All Share
Börsen: Berliner Wertpapierbörse / free trade
Hamburger Wertpapierbörse / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade
Bayerische Börse / free trade
Bremer Wertpapierbörse (BWB) / free trade
Frankfurter Wertpapierbörse / official dealing
Niedersächsische Börse zu Hannover / official dealing